S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Wall Street inches lower as retailers post holiday numbers
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
Ohio foundation begins process to distribute millions in opioid settlement money

bluebird bio (BLUE) Short Interest Ratio & Short Volume

$1.53
-0.03 (-1.92%)
(As of 03/4/2024 ET)

bluebird bio Short Interest Data

Current Short Volume
28,590,000 shares
Previous Short Volume
27,500,000 shares
Change Vs. Previous Month
+3.96%
Dollar Volume Sold Short
$30.88 million
Short Interest Ratio / Days to Cover
2.2
Last Record Date
February 15, 2024
Outstanding Shares
109,340,000 shares
Percentage of Shares Shorted
26.15%
Today's Trading Volume
10,882,290 shares
Average Trading Volume
10,164,586 shares
Today's Volume Vs. Average
107%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling bluebird bio ?

Sign up to receive the latest short interest report for bluebird bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BLUE Short Interest Over Time

BLUE Days to Cover Over Time

BLUE Percentage of Float Shorted Over Time


bluebird bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/202428,590,000 shares $30.88 million +4.0%N/A2.2 $1.08
1/31/202427,500,000 shares $28.05 million +3.5%N/A2.3 $1.02
1/15/202426,570,000 shares $39.86 million +10.3%N/A2.4 $1.50
12/31/202324,090,000 shares $33.24 million -5.4%N/A2.4 $1.38
12/15/202325,470,000 shares $83.29 million +16.6%N/A2.8 $3.27
11/30/202321,850,000 shares $83.47 million -2.9%N/A4.7 $3.82
11/15/202322,490,000 shares $73.99 million -8.5%N/A6.4 $3.29
10/31/202324,570,000 shares $72.48 million -0.4%N/A7 $2.95
10/15/202324,670,000 shares $65.62 million +2.3%N/A7 $2.66
9/30/202324,110,000 shares $73.29 million -17.0%N/A5.8 $3.04
9/15/202329,040,000 shares $97.28 million +11.5%N/A7 $3.35
8/31/202326,040,000 shares $98.17 million -1.6%N/A6.3 $3.77
8/15/202326,450,000 shares $95.75 million -8.3%N/A6.2 $3.62
7/31/202328,840,000 shares $113.34 million +13.7%N/A6.6 $3.93
7/15/202325,360,000 shares $76.84 million -21.5%N/A5.8 $3.03
6/30/202332,300,000 shares $106.27 million +6.1%N/A8.1 $3.29
6/15/202330,440,000 shares $121.46 million +23.0%N/A6.8 $3.99
5/31/202324,740,000 shares $82.88 million +5.3%N/A5.2 $3.35
5/15/202323,490,000 shares $96.78 million -0.3%N/A5 $4.12
4/30/202323,550,000 shares $102.44 million -0.8%N/A5.3 $4.35
4/15/202323,740,000 shares $74.07 million -10.3%N/A5.5 $3.12
3/31/202326,450,000 shares $84.11 million +29.0%N/A6.1 $3.18
3/15/202320,510,000 shares $95.37 million +12.2%N/A5.4 $4.65
2/28/202318,280,000 shares $95.06 million +5.5%N/A5.4 $5.20
2/15/202317,320,000 shares $102.88 million +0.2%N/A5.1 $5.94
1/31/202317,290,000 shares $109.79 million -6.3%N/A4.7 $6.35
1/15/202318,450,000 shares $145.57 million +1.2%N/A4.9 $7.89
12/30/202218,240,000 shares $126.22 million -1.1%N/A5.3 $6.92
12/15/202218,450,000 shares $143.54 million +1.0%N/A4.6 $7.78
11/30/202218,270,000 shares $142.32 million -5.2%N/A3.3 $7.79
11/15/202219,270,000 shares $148.38 million -14.5%N/A3.2 $7.70
10/31/202222,540,000 shares $141.33 million +0.5%N/A3.1 $6.27
10/15/202222,440,000 shares $143.39 million -1.2%N/A2.9 $6.39
9/30/202222,710,000 shares $143.75 million +13.0%N/A2.9 $6.33
9/15/202220,100,000 shares $142.51 million +1.8%N/A2.4 $7.09
8/31/202219,740,000 shares $115.28 million +19.9%N/A2 $5.84
8/15/202216,460,000 shares $112.42 million +8.4%N/A1.8 $6.83
7/31/202215,190,000 shares $61.52 million +13.3%N/A2 $4.05
7/15/202213,410,000 shares $64.50 million -11.1%N/A2 $4.81
6/30/202215,090,000 shares $62.47 million -13.8%N/A2.3 $4.14













BLUE Short Interest - Frequently Asked Questions

What is bluebird bio's current short interest?

Short interest is the volume of bluebird bio shares that have been sold short but have not yet been covered or closed out. As of February 15th, investors have sold 28,590,000 shares of BLUE short. Learn More on bluebird bio's current short interest.

What is a good short interest ratio for bluebird bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLUE shares currently have a short interest ratio of 2.0. Learn More on bluebird bio's short interest ratio.

Which institutional investors are shorting bluebird bio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of bluebird bio: GTS Securities LLC, Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is bluebird bio's short interest increasing or decreasing?

bluebird bio saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 28,590,000 shares, an increase of 4.0% from the previous total of 27,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does bluebird bio's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to bluebird bio: Vaxart, Inc. (8.26%), Graphite Bio, Inc. (2.70%), Genfit S.A. (0.19%), Sangamo Therapeutics, Inc. (5.49%), Adverum Biotechnologies, Inc. (4.52%), Solid Biosciences Inc. (2.03%), Opthea Limited (0.27%), Molecular Partners AG (0.17%), Mesoblast Limited (0.54%), X4 Pharmaceuticals, Inc. (7.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short bluebird bio stock?

Short selling BLUE is an investing strategy that aims to generate trading profit from bluebird bio as its price is falling. BLUE shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against bluebird bio?

A short squeeze for bluebird bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLUE, which in turn drives the price of the stock up even further.

How often is bluebird bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLUE, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:BLUE) was last updated on 3/5/2024 by MarketBeat.com Staff